• Caspase-3 Fluorometric Assay Kit in RCC Apoptosis

  2026-08-27

  Learn how the Caspase-3 Fluorometric Assay Kit can distinguish executioner-caspase activation from broader cell-death outcomes in renal cancer research. This article translates autophagy–apoptosis findings into practical assay design, controls, and interpretation strategies.

• Anti-RPS6 Antibody for Ribosome Signaling

  2026-08-27

  Discover how an Anti-RPS6 antibody can translate membrane-volume biology into measurable readouts of ribosomal activity, growth, and oncogenic signaling. This guide explains how MA4974 supports Western blot, ICC/IF, and IP assay design while clarifying what total RPS6 measurements can—and cannot—prove.

• Annexin V-Cy5/DAPI Apoptosis Kit Guide

  2026-08-26

  Learn how the Annexin V-Cy5/DAPI Apoptosis Kit (SKU K2255) distinguishes phosphatidylserine exposure from loss of membrane integrity in practical cell-death workflows. This scenario-based guide connects assay design, protocol control, interpretation, and vendor selection to mechanistic apoptosis research.

• QNZ (EVP4593): NF-κB Pathway Inhibitor

  2026-08-26

  QNZ (EVP4593) is a quinazoline derivative that inhibits NF-κB signaling in cellular inflammation assays. Its reported nanomolar benchmarks and activity in rat edema and YAC128 Huntington’s disease models support research use, but they do not establish clinical efficacy or human safety.

• ARCA Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-08-25

  Build a two-channel assay that separates mRNA delivery from protein expression in mammalian cells. This workflow uses Cy5 for direct cargo tracking and EGFP for translation readout, making it useful for comparing lipid nanoparticles, biodegradable polymers, and other mRNA delivery systems.

• DNA Damage Responses and Calicheamicin ADC Sensitivity

  2026-08-25

  This study combines genome-wide CRISPR/Cas9 screening with genetic and pharmacological validation to identify DNA damage response determinants of calicheamicin sensitivity in acute leukemia. TP53, ATM, and MDM2 emerged as important modulators, whereas PARP inhibition did not significantly enhance calicheamicin cytotoxicity, emphasizing the context dependence of DNA repair-targeted combinations.

• AMD-070 Hydrochloride: From Binding to Biology

  2026-08-24

  Explore AMD-070 hydrochloride as a selective CXCR4 antagonist through a translational framework linking receptor biology, WHIM syndrome outcomes, and functional assay design. This guide emphasizes endpoint selection, product handling, and the limits of extrapolating CXCR4 inhibition to anti-HIV research.

• EZ Cap™ Human PTEN mRNA: Assay Design Guide

  2026-08-24

  Discover how EZ Cap™ Human PTEN mRNA (ψUTP) can function as a controlled PTEN re-expression tool rather than merely a transfection reagent. This guide connects Cap 1 architecture, pseudouridine chemistry, pathway-level controls, and delivery-aware assay design for cancer research.

• DiscoveryProbe Protease Inhibitor Library Workflow

  2026-08-23

  Build a practical screening cascade that connects biochemical protease inhibition with cell-based mechanism studies. The workflow emphasizes hit confirmation, artifact control, apoptosis assay design, and responsible translation into cancer and infectious disease research.

• Cy5-UTP for Mechanism-Aware RNA Assays

  2026-08-22

  Cy5-UTP enables direct fluorescent RNA detection while preserving a clear link between probe chemistry and biological interpretation. This guide shows how Cyanine 5-uridine triphosphate can support mechanism-aware RNA probe synthesis, FISH design, and developmental RNA studies.

• Cy5-UTP for Mechanism-Driven RNA Imaging

  2026-08-22

  Cy5-UTP enables direct fluorescent RNA probe synthesis for FISH and dual-color expression arrays. This guide connects Cyanine 5-uridine triphosphate chemistry with assay decisions inspired by new MALAT1–TDP-43 research, emphasizing probe design, controls, and interpretive limits.

• Nilotinib (AMN-107) Assay Workflows

  2026-08-21

  Learn how Nilotinib (AMN-107) can distinguish pathway inhibition from true cancer-cell killing in BCR-ABL and KIT-driven models. This practical guide combines target-proximal readouts, viability assay design, dosing controls, and troubleshooting for more reproducible oncology experiments.

• L-NAME Hydrochloride in Vascular Research

  2026-08-20

  L-NAME Hydrochloride provides a practical way to suppress nitric oxide synthase while separating NO-dependent responses from prostaglandin-mediated vasorelaxation. This guide translates vascular organ-bath findings into workflows for vascular tone regulation studies, cell assays, and hypertension research, with troubleshooting guidance for concentration, timing, and pathway interpretation.

• (5Z)-7-Oxozeaenol TAK1 Inhibitor Workflows

  2026-08-20

  Build cleaner inflammation assays by separating TAK1-dependent NF-κB and JNK/p38 signaling from metabolic-stress adaptation. This workflow uses (5Z)-7-Oxozeaenol to interrogate IL-1 responses, COX-2 induction, and the AMPK–SQSTM1 feedback described in recent stress-biology research.

• BMS 599626 Dihydrochloride: State-Aware Assays

  2026-08-19

  BMS 599626 dihydrochloride is an EGFR and ErbB2 inhibitor suited to mechanistic cancer studies. This article explains how to interpret receptor inhibition across proliferative, stressed, and senescence-associated cell states while connecting assay design with machine-learning-guided discovery.

8050 records 1/537 page Next 12345 下5页 Last page